Intravenous Immunoglobulin May Be an Effective Therapy for Refractory, Active Diffuse Cutaneous Systemic Sclerosis.
CONCLUSION: Our observational study suggests that IVIG may be an effective adjunctive therapy for active dcSSc in patients failing other therapies.
PMID: 25433527 [PubMed - as supplied by publisher]
Source: J Rheumatol - Category: Rheumatology Authors: Poelman CL, Hummers LK, Wigley FM, Anderson C, Boin F, Shah AA Tags: J Rheumatol Source Type: research
More News: Clinical Trials | History of Medicine | Rheumatology | Scleroderma | Skin | Students | Study | Universities & Medical Training